Publication: 4022

Publication: 4022

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 42 (24) 2853-9

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 13

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA189830, UG1CA189954, UG1CA233290, UG1CA233180, UG1CA233337, UG1CA233339; U10CA180863, CCS 707213 (CCTG); U10CA180794, U10CA180820, UG1CA233234 (ECOG-ACRIN); U10CA180868 (NRG Oncology); U10CA180888. UG1CA233163 (SWOG)

Corr. Author:
Authors:: Jonathan A Nowak Tyler Twombly Chao Ma Qian Shi Koichiro Haruki Kenji Fujiyoshi Juha Väyrynen Melissa Zhao James Knight Shrikant Mane Ardaman Shergill Pankaj Kumar Felix Couture Philip Kuebler Smitha Krishnamurthi Benjamin Tan Philip Philip Eileen M O'Reilly Anthony F Shields Shuji Ogino Charles S Fuchs Jeffrey A Meyerhardt

Networks:: HEARTLAND, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, OH027

Study: Alliance-A151939
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80702
Phases:: N/A, 3

Keywords: